Our Partners

RSS Investor Relations and News

  • MYOS RENS Technology to Provide Exciting Updates on New Product and Clinical Research at the Veterinary Meeting & Expo in Orlando, January 19-22, 2020 January 15, 2020
    One-of-a Kind Product Backed by Clinical Science Improves Muscle Health in Dogs CEDAR KNOLLS, N.J., Jan. 15, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build lean [...]
    MYOS CEO Joseph Mannello Issues Letter to Shareholders January 09, 2020
    2019 in Review and Going Forward... 'It's All About the Fortetropin' CEDAR KNOLLS, N.J., Jan. 9, 2020 /PRNewswire/ -- MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps build [...]
    Learn More ›
  • International Conference on Frailty and Sarcopenia Research

    Toulouse, France

    North American Veterinary Meeting & Expo

    Orlando, Florida

Stock Snapshot

MYOS Symbol
NASDAQ Market
Market Cap
Price
Change
Volume